Literature DB >> 4380787

Fatal viral encephalitis following 17D yellow fever vaccine inoculation. Report of a case in a 3-year-old child.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 4380787     DOI： 10.1001/jama.1966.03110190153047

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

1.  A yellow fever vaccine free from avian leucosis viruses.

Authors:  C C Draper
Journal:  J Hyg (Lond)       Date:  1967-12

2.  Recombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases.

Authors:  A McAllister; A E Arbetman; S Mandl; C Peña-Rossi; R Andino
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

Review 3.  Yellow fever: a reemerging threat.

Authors:  Christina L Gardner; Kate D Ryman
Journal:  Clin Lab Med       Date:  2010-03       Impact factor: 1.935

Review 4.  Wanted, dead or alive: new viral vaccines.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Antiviral Res       Date:  2009-09-04       Impact factor: 5.970

5.  Pathophysiologic and transcriptomic analyses of viscerotropic yellow fever in a rhesus macaque model.

Authors:  Flora Engelmann; Laurence Josset; Thomas Girke; Byung Park; Alex Barron; Jesse Dewane; Erika Hammarlund; Anne Lewis; Michael K Axthelm; Mark K Slifka; Ilhem Messaoudi
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20

Review 6.  Yellow fever vaccine-associated viscerotropic disease: current perspectives.

Authors:  Roger E Thomas
Journal:  Drug Des Devel Ther       Date:  2016-10-12       Impact factor: 4.162

Review 7.  Questions regarding the safety and duration of immunity following live yellow fever vaccination.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Expert Rev Vaccines       Date:  2016-06-20       Impact factor: 5.683

Review 8.  A clinician's perspective on yellow fever vaccine-associated neurotropic disease.

Authors:  Elien Lecomte; Guy Laureys; Frederick Verbeke; Cristina Domingo Carrasco; Marjan Van Esbroeck; Ralph Huits
Journal:  J Travel Med       Date:  2020-11-09       Impact factor: 8.490
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.